We have developed a recombinant live oral vaccine using the ice-nucleation
protein (Inp) from Pseudomonas syringae to display viral antigens on the su
rface of Salmonella spp. Fusion proteins containing viral antigens were exp
ressed in the oral vaccine strain, Salmonella typhi Ty21a. Surface localiza
tion was verified by immunoblotting and fluorescence-activated cell sorting
. The immunogenicity of surface-displayed viral antigens on the recombinant
live vaccine strain was assessed in mice inoculated intranasally and intra
peritoneally. Inoculation resulted in significantly higher serum antibody l
evel than those induced by viral antigens expressed intracellularly. Thus,
this multivalent mucosal live vaccine may provide an effective means for in
ducing mucosal or systemic immune responses against multiple viral antigens
.